Publications by authors named "Kwee Yong"

100Publications

Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.

Neurology 2020 07 30;95(3):e268-e279. Epub 2020 Jun 30.

From the MRC Centre for Neuromuscular Disease, Neuroimmunology and CSF Laboratory (S.K., O.J.Z., H.M., A.C., M.M.R., M.P.L.), Institute of Neurology, Cancer Division (D.F., J.B., A.C., K.Y., S.D.), Department of Endocrinology (F.C., S.E.B., M.P.L.), and Division of Neuropathology, National Hospital for Neurology and Neurosurgery (Z.J., S.B.), University College London NHS Foundation Trust (S.K.), National Hospital for Neurology and Neurosurgery; Department of Neuromuscular Diseases (S.K., O.J.Z., H.M., A.C., M.M.R., M.P.L.), UCL Queen Square Institute of Neurology; and Department of Clinical Neurosciences (J.F., S.R.), John Radcliffe Hospital, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000009940DOI Listing
July 2020

The adapted Zelen was a feasible design to trial exercise in myeloma survivors.

J Clin Epidemiol 2020 Sep 11;125:76-83. Epub 2020 Apr 11.

Department of Behavioural Science and Health, University College London, WC1E 7HB, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2020.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482584PMC
September 2020

Assessing the safety of autologous stem cell transplant pathway via ambulatory care for patients with multiple myeloma.

Hematol Oncol Stem Cell Ther 2020 Mar 12. Epub 2020 Mar 12.

Department of Haematology, University College London Hospitals, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hemonc.2020.01.001DOI Listing
March 2020

Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial.

Haematologica 2020 05 27;105(5):e261-e263. Epub 2020 Feb 27.

National Institute for Health Research Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust & University College London Institute of Ophthalmology, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.235937DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193475PMC
May 2020

Levofloxacin prophylaxis in patients with myeloma - Authors' reply.

Lancet Oncol 2020 02;21(2):e69

Warwick Clinical Trials Unit, University of Warwick, Coventry, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(20)30020-6DOI Listing
February 2020

Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design.

Future Oncol 2020 Jan 13;16(2):4347-4358. Epub 2019 Dec 13.

Department of Hematology, University of California at San Francisco, San Francisco, CA, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0431DOI Listing
January 2020

Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?

Haematologica 2019 11;104(11):2128-2131

Hematology and Oncology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.228684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821633PMC
November 2019

Oral proteasome inhibitor maintenance for multiple myeloma.

Lancet 2019 01 10;393(10168):204-205. Epub 2018 Dec 10.

Department of Haematology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)33128-3DOI Listing
January 2019

Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016.

Br J Haematol 2019 06 22;185(5):981-984. Epub 2018 Nov 22.

Department of Haematology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15680DOI Listing
June 2019

Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome.

Neurol Neuroimmunol Neuroinflamm 2018 Sep 15;5(5):e486. Epub 2018 Aug 15.

MRC Centre for Neuromuscular Diseases (M.P., S.K., M.M.R., M.P.L.), National Hospital for Neurology and Neurosurgery, Queen Square, London, UK; Cancer Division (S.D., K.L.Y.), University College London Hospitals NHS Foundation Trust, London, UK; and Department of Neuroimmunology (A.J.C., M.P.L.), Institute of Neurology, Queen Square, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000486DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117193PMC
September 2018

National survey of imaging practice for suspected or confirmed plasma cell malignancies.

Br J Radiol 2018 Dec 1;91(1092):20180462. Epub 2018 Nov 1.

1 Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London , London , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjr.20180462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319860PMC
December 2018

Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials.

Br J Haematol 2019 04 5;185(2):344-347. Epub 2018 Jul 5.

NIHR/UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15457DOI Listing
April 2019

More convenient proteasome inhibition for improved outcomes.

Lancet Oncol 2018 07 1;19(7):856-858. Epub 2018 Jun 1.

UCL Cancer Institute, University College London, Gower Street, London, WC1E 6BT, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30411-XDOI Listing
July 2018

The start of a new wave: Developments in proteasome inhibition in multiple myeloma.

Eur J Haematol 2018 Mar 30. Epub 2018 Mar 30.

University Hospital Ostrava, Ostrava, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13071DOI Listing
March 2018

Real world data of the impact of first cycle daratumumab on multiple myeloma and AL amyloidosis services.

Br J Haematol 2018 09 18;182(6):936-939. Epub 2017 Aug 18.

University College London Hospitals NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14897DOI Listing
September 2018

Guidelines for screening and management of late and long-term consequences of myeloma and its treatment.

Br J Haematol 2017 Mar 20;176(6):888-907. Epub 2017 Jan 20.

University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14514DOI Listing
March 2017

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management.

Hematol Oncol 2017 Dec 2;35(4):432-439. Epub 2016 Nov 2.

Department of Haematology, Cancer Institute, University College London, London, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hon.2345
Publisher Site
http://dx.doi.org/10.1002/hon.2345DOI Listing
December 2017

Advances in understanding prognosis in myeloma.

Br J Haematol 2016 Nov 8;175(3):367-380. Epub 2016 Sep 8.

Department of Haematology, University College, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14304DOI Listing
November 2016

Multiple myeloma: patient outcomes in real-world practice.

Br J Haematol 2016 Oct 13;175(2):252-264. Epub 2016 Jul 13.

'Seràgnoli' Institute of Hematology and Medical Oncology, Bologna University School of Medicine, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096152PMC
October 2016

Spinal disease in myeloma: cohort analysis at a specialist spinal surgery centre indicates benefit of early surgical augmentation or bracing.

BMC Cancer 2016 07 11;16:444. Epub 2016 Jul 11.

Spinal Deformity Unit, Department of Spinal Surgery, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, HA7 4LP, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2495-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939590PMC
July 2016

Multiple myeloma: practice patterns across Europe.

Br J Haematol 2016 10 13;175(1):66-76. Epub 2016 Jun 13.

Department of Haematology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14193DOI Listing
October 2016

Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in Myeloma.

Biol Blood Marrow Transplant 2016 11 8;22(11):1926-1937. Epub 2016 Jun 8.

Department of Haematology, Oxford University Hospitals NHS Trust, United Kingdom; NIHR Biomedical Research Centre, Blood Theme, Oxford, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.06.004DOI Listing
November 2016

Cyclin D type does not influence cell cycle response to DNA damage caused by ionizing radiation in multiple myeloma tumours.

Br J Haematol 2016 06 4;173(5):693-704. Epub 2016 May 4.

Department of Haematology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13982DOI Listing
June 2016

Real world experience of bortezomib re-treatment for patients with multiple myeloma at first relapse.

Br J Haematol 2017 05 8;177(3):495-497. Epub 2016 Apr 8.

Department of Haematology, University College London Hospitals NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14086DOI Listing
May 2017

Myeloma impairs mature osteoblast function but causes early expansion of osteo-progenitors: temporal changes in bone physiology and gene expression in the KMS12BM model.

Br J Haematol 2016 Jan 2;172(1):64-79. Epub 2015 Nov 2.

Department of Haematology, Cancer Institute, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13790DOI Listing
January 2016

Multiple myeloma and physical activity: a scoping review.

BMJ Open 2015 Nov 27;5(11):e009576. Epub 2015 Nov 27.

Department of Epidemiology and Public Health, Health Behaviour Research Centre, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2015-009576DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663409PMC
November 2015

Time to redefine Myeloma.

Br J Haematol 2015 Oct 27;171(1):1-10. Epub 2015 Jul 27.

Department of Haematology, University Hospitals Bristol Foundation Trust, Bristol, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13620DOI Listing
October 2015

17P deleted multiple myeloma presenting with intracranial disease: durable remission after tailored management.

Hematol Oncol 2016 Sep 15;34(3):165-70. Epub 2015 Jun 15.

Clinical Haematology, University College London NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2208DOI Listing
September 2016

Global hypomethylation in myeloma is associated with poor prognosis.

Br J Haematol 2016 Feb 26;172(3):473-5. Epub 2015 May 26.

Department of Haematology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13506DOI Listing
February 2016

Cohort analysis of FISH testing of CD138(+) cells in relapsed multiple myeloma: implications for prognosis and choice of therapy.

Br J Haematol 2015 Dec 21;171(5):881-3. Epub 2015 Apr 21.

Department of Haematology, UCL Cancer Institute, London, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.13446
Publisher Site
http://dx.doi.org/10.1111/bjh.13446DOI Listing
December 2015

RAS mutation status and bortezomib therapy for relapsed multiple myeloma.

Br J Haematol 2015 Jun 12;169(6):905-8. Epub 2015 Jan 12.

Department of Haematology, Cancer Institute, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13258DOI Listing
June 2015

Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide.

Ann Hematol 2015 Apr 28;94(4):643-9. Epub 2014 Oct 28.

Level 2, Cancer and Hematology Centre, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, OX3 7LE, UK,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2238-2DOI Listing
April 2015

An alternative dosing strategy of lenalidomide for patients with relapsed multiple myeloma.

Br J Haematol 2015 Jan 8;168(1):148-51. Epub 2014 Aug 8.

University College London Hospitals NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13072DOI Listing
January 2015

The effects of CAMPATH-1H on cell viability do not correlate to the CD52 density on the cell surface.

PLoS One 2014 22;9(7):e103254. Epub 2014 Jul 22.

University College London, Cancer Institute, London, United Kingdom; Anthony Nolan Research Institute, London, United Kingdom.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0103254PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106894PMC
November 2015

Updates to the guidelines for the diagnosis and management of multiple myeloma.

Br J Haematol 2014 Oct 7;167(1):131-3. Epub 2014 May 7.

School of Cancer Studies, University of Birmingham, Birmingham, UK; Department of Haematology, Heart of England NHS Foundation Trust, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12926DOI Listing
October 2014

Plasma cell neoplasm associated chronic neutrophilic leukemia with membrane proximal and truncating CSF3R mutations.

Leuk Lymphoma 2014 Jul 1;55(7):1661-2. Epub 2013 Nov 1.

Department of Haematology, University College London Hospital , London , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.842990DOI Listing
July 2014

Myeloma presenting during pregnancy.

Hematol Oncol 2014 Mar 1;32(1):52-5. Epub 2013 Sep 1.

Clinical Haematology, University College Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2088DOI Listing
March 2014

Multiple myeloma.

BMJ 2013 Jun 26;346:f3863. Epub 2013 Jun 26.

Department of Haematology, University College Hospital, London NW1 2PG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.f3863DOI Listing
June 2013

Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma.

Eur J Haematol 2013 May 14;90(5):420-5. Epub 2013 Mar 14.

Department of Haematology, University College London Hospital (UCLH), London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12070DOI Listing
May 2013

Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma.

PLoS One 2012 29;7(8):e41127. Epub 2012 Aug 29.

Department of Human Metabolism, University of Sheffield Faculty of Medicine, Dentistry and Health, Sheffield, United Kingdom.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0041127PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430669PMC
February 2013

Improved response with post-ASCT consolidation by low dose thalidomide, cyclophosphamide and dexamethasone as first line treatment for multiple myeloma.

Br J Haematol 2012 Aug 19;158(4):499-505. Epub 2012 Jun 19.

Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2141.2012.09188.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2012.09188.xDOI Listing
August 2012

Guidelines for the diagnosis and management of multiple myeloma 2011.

Br J Haematol 2011 Jul 14;154(1):32-75. Epub 2011 May 14.

Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2011.08573.xDOI Listing
July 2011

APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status.

Blood 2011 Jan 13;117(3):890-901. Epub 2010 Aug 13.

Department of Haematology, University College London Cancer Institute, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-01-264424DOI Listing
January 2011

Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO.

J Immunol 2010 Apr 15;184(8):4317-26. Epub 2010 Mar 15.

Division of Infection and Immunity, Department of Immunology, University College London, London W1T 4JF, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0903781DOI Listing
April 2010

An unusual case of myocardial infarction.

BMJ Case Rep 2010 5;2010. Epub 2010 Apr 5.

University College London Hospital, Haematology, Department of Haematology, 1st Floor Central, London, NW1 2PJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr.11.2009.2422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047522PMC
October 2012

Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model.

Haematologica 2008 Oct 25;93(10):1457-65. Epub 2008 Aug 25.

UCL Cancer Institute, 72 Huntley Street, London Wc1E 6DD, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.12553DOI Listing
October 2008